Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chantix for smoking cessation in patients with Acute Coronary Syndrome
NCT01170338Phase 4Unknown
- Sponsor
- Newark Beth Israel Medical Center
- Start
- Jan 2008
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of varenicline in nicotine dependence, sponsored by Newark Beth Israel Medical Center. Status: unknown.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT01170338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01170338.